The US Food & Drug Administration (FDA) has granted fast track designations for both the intravenous (IV) and oral formulations of Tetraphase Pharmaceuticals' lead antibiotic candidate, eravacycline.
Many are well informed about different diseases that involve oral cavities. Fortunately, several medications assist in treating these diseases. Dentists or
dental professionals prescribe drugs for dental care, depending on the issue. Specific medications are offered to prevent or treat infection, reduce anxiety,
minimize pain and inflammation, treat bacterial infections, teeth cleaning or whitening, and many others.
Overall, this article will get you acquainted with some types of medications dental professionals use in caring for their patient's teeth. If you want to know them,
then read them on.
1. Conscious Sedation Drugs
Many individuals experience anxiety when visiting a dentist. As such, a dentist may apply conscious sedation to ease such feelings. Conscious sedation is part
of sedation dentistry in which a dentist alleviates dental anxiety by using sedative medications.
The National Institutes of Health stated that you'll still be awake through conscious sedation. However, you'll become more unmindful of the dental procedure.
Also, you may forget what occurred afterward. Note that conscious sedation differs from general anesthesia, which assists in making you wholly unconscious, and
dentists generally employ this for lengthy dental procedures.
Adding to the growing evidence of global medicine shortages, a new study has revealed that the European generic medicines market is "not in shape" to help
Europe meet its public health priorities.
In the past decade, the rate of generic medicines withdrawals has risen by 12 per cent, while there has been a three per cent decrease in the launch of generic
products, as per Teva Pharmaceuticals' recent analysis of IQVIA data.
Within the mental therapeutic area, seven per cent of generic products disappeared between 2013 and 2023, while there was a seven per cent decrease in the
availability of generic cancer medicines in just six years (2017-2022).
These medicines were listed on the Union List of Critical Medicines to help avoid potential shortages, as the European Commission (EC) said this could cause
"significant harm to patients and pose important challenges to health systems."
While mature generic products constitute the majority of the List, they remain susceptible to withdrawals, despite containing products crucial for safeguarding
Europe's public health, the Teva analysis report noted.
Since 2013, the number of generic products for the treatment of schizophrenia and bipolar disorder has declined by 25 per cent, with Hungary and Bulgaria
experiencing the biggest loss at 83 per cent and 58 per cent respectively.